A Multicenter, Single Arm, Phase 2 Clinical Study on the Combination of Radiation Therapy and Ipilimumab, for the Treatment of Patients With Melanoma and Brain Metastases
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Ipilimumab (Primary)
- Indications Brain metastases; Malignant melanoma
- Focus Therapeutic Use
- Acronyms GEM STUDY; GRAY B
- 07 Jun 2017 Biomarkers information updated
- 23 Feb 2017 Planned End Date changed from 1 Oct 2016 to 1 Dec 2017.
- 23 Feb 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Dec 2017.